EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center

Ju Hee Kim iD, Hana Saeed Alzahrani iD, Sa Ra Lee iD, Sung Hoon Kim iD, Hee Dong Chae iD

Yonsei Medical Journal · 2023

DOI: 10.3349/ymj.2023.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yonsei Medical Journal, 2023. Verfasst von Ju Hee Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report our experience of fertility preservation (FP) in female cancer patients. MATERIALS AND METHODS: We retrospectively analyzed the medical records of female who underwent elective oocyte or embryo cryopreservation before cancer treatment between January 2015 and December 2020 at Asan Medical Center. We analyzed the type of cancer, the rate of reuse of cryopreserved oocytes or embryos, and fertility outcomes such as the resumption of menstruation or pregnancy. RESULTS: A total of 174 patients underwent 182 oocyte retrieval cycles after controlled ovarian stimulation for oocyte or embryo cryopreservation. The median age of patients was 33.0 (range 19-46) years, and the patients were most unmarried female (65.52%). The majority of patients were diagnosed with breast cancer (78.16%), and the remaining were diagnosed with gastrointestinal (6.33%) and hematologic malignancies (5.75%). The maturation rate of oocyte cryopreservation was 83.33%, and the fertilization rate of embryo cryopreservation was 72.07%. Of the 57 patients currently not undergoing cancer treatment, 34 resumed menstruating and 19 (33.33%, 19/57) returned to attempt a pregnancy. Among them, five patients succeeded in natural pregnancy. Eleven patients received frozen-thawed embryo transfer, and four patients succeeded in becoming pregnant (36.36%, 4/11). Only 6.3% of patients returned to use their gametes, and 93.7% of gametes are still in storage. CONCLUSION: FP in cancer patients should be considered before cancer treatment. Through continuous research on oncofertility, it is necessary to consider how to increase the return rate and provide appropriate information to cancer patients of reproductive age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationNeoplasmsFemalePregnancyHumansRetrospective StudiesCryopreservationOocytes

Stichwörter der Autor:innen

Fertility preservationcancerembryo cryopreservationoncofertilityoocyte cryopreservation

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. hdchae@amc.seoul.kr.

ORCID-Profile: Ju Hee Kim, Hana Saeed Alzahrani, Sa Ra Lee, Sung Hoon Kim, Hee Dong Chae

Zitieren

APA

Kim, J. H., Alzahrani, H. S., Lee, S. R., Kim, S. H., & Chae, H. D. (2023). Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2023.0009

Vancouver

Kim JH, Alzahrani HS, Lee SR, Kim SH, Chae HD. Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center. Yonsei Medical Journal. 2023. doi:10.3349/ymj.2023.0009

BibTeX
@article{Kim2023,
  author = {Kim, Ju Hee and Alzahrani, Hana Saeed and Lee, Sa Ra and Kim, Sung Hoon and Chae, Hee Dong},
  title = {Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center},
  journal = {Yonsei Medical Journal},
  year = {2023},
  doi = {10.3349/ymj.2023.0009}
}
Kostenlos starten →